These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 18192287)

  • 1. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
    Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
    Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.
    Snowden JS; Pickering-Brown SM; Mackenzie IR; Richardson AM; Varma A; Neary D; Mann DM
    Brain; 2006 Nov; 129(Pt 11):3091-102. PubMed ID: 17003069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
    Gass J; Cannon A; Mackenzie IR; Boeve B; Baker M; Adamson J; Crook R; Melquist S; Kuntz K; Petersen R; Josephs K; Pickering-Brown SM; Graff-Radford N; Uitti R; Dickson D; Wszolek Z; Gonzalez J; Beach TG; Bigio E; Johnson N; Weintraub S; Mesulam M; White CL; Woodruff B; Caselli R; Hsiung GY; Feldman H; Knopman D; Hutton M; Rademakers R
    Hum Mol Genet; 2006 Oct; 15(20):2988-3001. PubMed ID: 16950801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
    Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
    Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
    Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
    Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
    Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
    J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
    Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
    Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series.
    Borroni B; Archetti S; Alberici A; Agosti C; Gennarelli M; Bigni B; Bonvicini C; Ferrari M; Bellelli G; Galimberti D; Scarpini E; Di Lorenzo D; Caimi L; Caltagirone C; Di Luca M; Padovani A
    Neurogenetics; 2008 Jul; 9(3):197-205. PubMed ID: 18392865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heritability and genetics of frontotemporal lobar degeneration.
    Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
    Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of frontotemporal dementia patients with a Progranulin mutation.
    Huey ED; Grafman J; Wassermann EM; Pietrini P; Tierney MC; Ghetti B; Spina S; Baker M; Hutton M; Elder JW; Berger SL; Heflin KA; Hardy J; Momeni P
    Ann Neurol; 2006 Sep; 60(3):374-80. PubMed ID: 16983677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
    Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
    Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration.
    Skoglund L; Ingvast S; Matsui T; Freeman SH; Frosch MP; Brundin R; Giedraitis V; Growdon JH; Hyman BT; Lannfelt L; Ingelsson M; Glaser A
    Dement Geriatr Cogn Disord; 2009; 28(5):471-5. PubMed ID: 19940479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
    Robinson AC; Thompson JC; Weedon L; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):844-54. PubMed ID: 24861427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic contributors to frontotemporal lobar degeneration: beyond monogenic disease.
    Borroni B; Pilotto A; Bianchi M; Gilberti N; Padovani A
    Mini Rev Med Chem; 2011 Oct; 11(11):988-1001. PubMed ID: 21762097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).
    Gabryelewicz T; Masellis M; Berdynski M; Bilbao JM; Rogaeva E; St George-Hyslop P; Barczak A; Czyzewski K; Barcikowska M; Wszolek Z; Black SE; Zekanowski C
    J Alzheimers Dis; 2010; 22(4):1123-33. PubMed ID: 20930269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
    Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal lobar degeneration: clinical and pathological relationships.
    Snowden J; Neary D; Mann D
    Acta Neuropathol; 2007 Jul; 114(1):31-8. PubMed ID: 17569065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration.
    Krüger J; Kaivorinne AL; Udd B; Majamaa K; Remes AM
    Eur J Neurol; 2009 Jan; 16(1):27-30. PubMed ID: 19049508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
    Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.